AMASS Brands Inc. Stock Trading Halted Due to Volatility
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
AMASS Brands Inc. Common Stock trading halted, volatility trading pause
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMSS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMSS
Wall Street analysts forecast AMSS stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 6.430
Low
Averages
High
Current: 6.430
Low
Averages
High

No data
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Successful Direct Listing: AMASS Brands Group commenced trading on the Nasdaq Capital Market under the ticker symbol 'AMSS' on Wednesday, with the direct listing not involving new share issuance, indicating the company's stability and transparency in the capital market.
- Diverse Brand Portfolio: AMASS operates a portfolio of nine beverage brands across non-alcoholic, functional wellness, and alcoholic categories, including Good Twin Non-Alcoholic Wine and Summer Water Rosé, showcasing its broad positioning in the beverage market.
- Strong Revenue Performance: Since inception, AMASS has generated over $80 million in cumulative revenue and sold more than 5.7 million bottles, reflecting the popularity of its products and consumer acceptance in the market.
- Expanded Distribution Network: AMASS's products are now available at over 40,000 points of sale, indicating a significant increase in market penetration and brand influence, further enhancing the company's competitive position.
See More
- Successful Pricing of Lincoln Financial: Lincoln Financial (LCLN) priced at $421 million, achieving a market cap of $2.2 billion, indicating strong demand in the private capital markets despite geopolitical and private credit concerns affecting peers.
- Direct Listing of AMASS Brands: Beverage company AMASS Brands (AMSS) completed its direct listing on Nasdaq, yet its stock fell 52% from the $8.98 price of its last funding round, reflecting market caution towards its premium beverage platform.
- Conexeu Sciences Surge: Medical device developer Conexeu Sciences (CNXU) completed a direct listing on Nasdaq, with its stock soaring 260% from the $4.00 price of its most recent private placement, showcasing investor enthusiasm for its unique regenerative medical technology.
- SPACs Pricing Overview: Seven SPACs priced this week, with Oceanhawk Acquisition (OHACU) raising $160 million and Aperture AC (APURU) raising $90 million, demonstrating ongoing market interest in blank check companies despite an uncertain overall market environment.
See More
- Direct Listing Overview: AMASS Brands successfully completed a direct listing on Nasdaq, with existing shareholders planning to sell up to 14.3 million shares of common stock, indicating increased recognition in the capital markets.
- Market Valuation: With an expected reference price of $16.00 per share, AMASS Brands commands an estimated market value of approximately $134 million, reflecting its potential in the premium beverage sector.
- Product Portfolio and Market Positioning: AMASS Brands focuses on developing and marketing both alcoholic and non-alcoholic beverages, with offerings like Good Twin Non-Alcoholic Wine and Calirosa Tequila, aligning with consumer trends towards premiumization and wellness-oriented drinking.
- Strategic Acquisition: In 2023, AMASS Brands acquired the assets of Winc, which raised $22 million in its 2021 IPO, further enhancing its market competitiveness and brand influence.
See More








